short acting glp 1 agonists GLP-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? Treatment with GLP-1 Receptor Agonists

Mol Cell 14(3):395403 Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD, Glass DJ (2005) Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway

By courtesy of the late M

Omics could bring new insights into the importance of personalized therapeutic nutrition [410]

Have questions

TMAO was found to exacerbate myocardial hypertrophy and cardiac fibrosis in rodent models with transverse aortic constriction and also in mouse models of doxorubicin (DOX)-induced cardiac fibrosis (Organ et al., 2016

Pour 1 glule : L-glutathion : 50mg Conditionnement : Bote de 30 glules